SG11202108940RA - Novel heterotricyclic derivative compound and use of same - Google Patents
Novel heterotricyclic derivative compound and use of sameInfo
- Publication number
- SG11202108940RA SG11202108940RA SG11202108940RA SG11202108940RA SG11202108940RA SG 11202108940R A SG11202108940R A SG 11202108940RA SG 11202108940R A SG11202108940R A SG 11202108940RA SG 11202108940R A SG11202108940R A SG 11202108940RA SG 11202108940R A SG11202108940R A SG 11202108940RA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- derivative compound
- heterotricyclic
- novel
- novel heterotricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190019544A KR20200101219A (ko) | 2019-02-19 | 2019-02-19 | 신규한 헤테로트리시클릭 유도체 화합물 및 이의 용도 |
| PCT/KR2020/002427 WO2020171606A1 (ko) | 2019-02-19 | 2020-02-19 | 신규한 헤테로트리시클릭 유도체 화합물 및 이의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108940RA true SG11202108940RA (en) | 2021-09-29 |
Family
ID=72144293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108940RA SG11202108940RA (en) | 2019-02-19 | 2020-02-19 | Novel heterotricyclic derivative compound and use of same |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220135582A1 (zh) |
| EP (1) | EP3929199A4 (zh) |
| JP (1) | JP7358491B2 (zh) |
| KR (1) | KR20200101219A (zh) |
| CN (1) | CN113423710A (zh) |
| AU (1) | AU2020226042B2 (zh) |
| BR (1) | BR112021016448A2 (zh) |
| CA (1) | CA3130456C (zh) |
| CL (1) | CL2021002165A1 (zh) |
| EA (1) | EA202191991A1 (zh) |
| IL (1) | IL285604A (zh) |
| MX (1) | MX2021009854A (zh) |
| PE (1) | PE20211703A1 (zh) |
| SG (1) | SG11202108940RA (zh) |
| TW (1) | TWI829869B (zh) |
| WO (1) | WO2020171606A1 (zh) |
| ZA (1) | ZA202105970B (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3100977A1 (en) | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| KR102386403B1 (ko) * | 2020-08-13 | 2022-04-15 | 한미약품 주식회사 | 신규한 디옥솔로이소퀴놀린온 유도체 화합물 및 이의 용도 |
| EP4196483A1 (en) * | 2020-08-13 | 2023-06-21 | Hanmi Pharmaceutical Co., Ltd. | Novel dioxoloisoquinolinone derivatives and use thereof |
| WO2022179584A1 (zh) * | 2021-02-26 | 2022-09-01 | 南京药石科技股份有限公司 | 新型ezh2抑制剂及其用途 |
| WO2023217018A1 (zh) * | 2022-05-07 | 2023-11-16 | 贝达药业股份有限公司 | Ezh2抑制剂及其在医药上的应用 |
| TW202400602A (zh) * | 2022-05-31 | 2024-01-01 | 大陸商和記黃埔醫藥（上海）有限公司 | 三環類化合物及其用途 |
| WO2023244918A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | Quinolone bcl6 bifunctional degraders |
| WO2023244917A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | 1,8-naphthyridin-2-one heterobifunctional bcl6 degraders |
| WO2024038115A1 (en) | 2022-08-17 | 2024-02-22 | Morphosys Ag | Therapy comprising anti-cd19 antibody and ezh2 modulators |
| CN115974856B (zh) * | 2022-12-28 | 2023-08-11 | 北京康立生医药技术开发有限公司 | 一种治疗成人t细胞白血病淋巴瘤药物伐美妥司他的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3438B1 (ar) | 2011-04-13 | 2019-10-20 | Epizyme Inc | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس |
| WO2013067302A1 (en) * | 2011-11-04 | 2013-05-10 | Glaxosmithkline Intellectual Property (No. 2) Limited | Method of treatment |
| UA111305C2 (uk) * | 2012-12-21 | 2016-04-11 | Пфайзер Інк. | Конденсовані лактами арилу та гетероарилу |
| WO2015077194A1 (en) * | 2013-11-22 | 2015-05-28 | Bristol-Myers Squibb Company | Inhibitors of lysine methyl transferase |
| PL3121175T3 (pl) * | 2014-03-17 | 2020-06-01 | Daiichi Sankyo Company, Limited | Pochodne 1,3-benzodioksolu jako inhibitory ezh1 i/lub ezh2 |
| WO2015193768A1 (en) | 2014-06-17 | 2015-12-23 | Pfizer Inc. | Aryl fused lactams as ezh2 modulators |
| MD4820C1 (ro) * | 2014-06-17 | 2023-03-31 | Pfizer Inc. | Compuşi dihidroizochinolinonici substituiţi |
| WO2016154434A1 (en) | 2015-03-25 | 2016-09-29 | The Regents Of The University Of California | Selective alpha-7 nicotinic receptor agonists and methods for making and using them |
| CA3100977A1 (en) * | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
-
2019
- 2019-02-19 KR KR1020190019544A patent/KR20200101219A/ko not_active Application Discontinuation
-
2020
- 2020-02-19 WO PCT/KR2020/002427 patent/WO2020171606A1/ko unknown
- 2020-02-19 AU AU2020226042A patent/AU2020226042B2/en active Active
- 2020-02-19 BR BR112021016448A patent/BR112021016448A2/pt unknown
- 2020-02-19 CA CA3130456A patent/CA3130456C/en active Active
- 2020-02-19 MX MX2021009854A patent/MX2021009854A/es unknown
- 2020-02-19 EP EP20759257.7A patent/EP3929199A4/en active Pending
- 2020-02-19 JP JP2021548205A patent/JP7358491B2/ja active Active
- 2020-02-19 US US17/431,933 patent/US20220135582A1/en active Pending
- 2020-02-19 TW TW109105374A patent/TWI829869B/zh active
- 2020-02-19 PE PE2021001370A patent/PE20211703A1/es unknown
- 2020-02-19 SG SG11202108940RA patent/SG11202108940RA/en unknown
- 2020-02-19 CN CN202080013624.0A patent/CN113423710A/zh active Pending
- 2020-02-19 EA EA202191991A patent/EA202191991A1/ru unknown
-
2021
- 2021-08-14 IL IL285604A patent/IL285604A/en unknown
- 2021-08-16 CL CL2021002165A patent/CL2021002165A1/es unknown
- 2021-08-19 ZA ZA2021/05970A patent/ZA202105970B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021009854A (es) | 2021-09-28 |
| PE20211703A1 (es) | 2021-09-01 |
| AU2020226042B2 (en) | 2022-07-14 |
| JP2022522648A (ja) | 2022-04-20 |
| KR20200101219A (ko) | 2020-08-27 |
| US20220135582A1 (en) | 2022-05-05 |
| EP3929199A4 (en) | 2022-10-26 |
| EA202191991A1 (ru) | 2021-12-10 |
| CA3130456A1 (en) | 2020-08-27 |
| WO2020171606A1 (ko) | 2020-08-27 |
| CN113423710A (zh) | 2021-09-21 |
| BR112021016448A2 (pt) | 2021-11-09 |
| AU2020226042A1 (en) | 2021-09-09 |
| IL285604A (en) | 2021-09-30 |
| CA3130456C (en) | 2023-10-03 |
| TWI829869B (zh) | 2024-01-21 |
| CL2021002165A1 (es) | 2022-04-22 |
| TW202045512A (zh) | 2020-12-16 |
| EP3929199A1 (en) | 2021-12-29 |
| ZA202105970B (en) | 2023-05-31 |
| JP7358491B2 (ja) | 2023-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202105970B (en) | Novel heterotricyclic derivative compound and use of same | |
| EP3919483A4 (en) | HETEROCYCLIC BENZOPYRIDONE COMPOUND AND USE THEREOF | |
| ZA202106304B (en) | Heterocyclic compound and use thereof | |
| EP3816154A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
| EP3589319A4 (en) | COMPOUNDS INTERACTING WITH GLYCAN AND METHODS OF USE | |
| EP3816153A4 (en) | HETEROCYCLIC COMPOUND AND ITS USE | |
| EP3886853A4 (en) | DIARYLHYDANTOI COMPOUNDS AND METHODS OF USE THEREOF | |
| IL285117A (en) | Methods for characterizing properties related to condensation of compounds and their uses | |
| EP3829307A4 (en) | BISMUTH-THIOL COMPOSITIONS AND METHODS OF USE | |
| EP3697791A4 (en) | HETEROCYCLIC COMPOUNDS, COMPOSITIONS INCLUDING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | |
| EP3907225A4 (en) | COMPOUNDS DERIVED FROM IMIDAZOPYRIDINE AND THEIR USE | |
| IL287026A (en) | Heterocyclic compounds and their uses | |
| IL276592A (en) | History of Subtirum | |
| IL286697A (en) | Neurogulin-4 compounds and methods of use | |
| IL276912A (en) | Heterocyclic compound and its use | |
| SG11202101308QA (en) | Novel magnesium-serinate compound and use thereof | |
| EP3915638A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
| EP3740468A4 (en) | SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHOD OF USING | |
| EP3738961A4 (en) | HETEROCYCLIC COMPOUND AS A CSF-1R INHIBITOR AND USE OF IT | |
| IL289336A (en) | Antibacterial compounds and methods of using them | |
| GB2589398B (en) | Compounds and methods of use | |
| EP3476227A4 (en) | COMPOSITIONS FOR LOW BREAKAGE CONTROL AND USES THEREOF | |
| ZA202105399B (en) | Use of spiropidion | |
| EP3976039A4 (en) | BISAMINOQUILINE AND BISAMINOACRIDINE COMPOUNDS AND METHODS OF USE | |
| EP4007497A4 (en) | BETA-ARRESTIN MODULATING COMPOUNDS AND METHODS OF USE THEREOF |